Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells
article
OA: closed
CC0
⤵ 24 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists were found to work together to inhibit the growth of immortalized endometrial stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (70)
- Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis via openalex
- Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis via openalex
- Altered maturation and function of peritoneal macrophages: Possible role in pathogenesis of endometriosis via openalex
- Angiogenesis and Macrophage Activation in Endometriosis via openalex
- Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells via openalex
- Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model via openalex
- Emerging drugs for endometriosis via openalex
- Estradiol and Interleukin-1β Exert a Synergistic Stimulatory Effect on the Expression of the Chemokine Regulated upon Activation, Normal T Cell Expressed, and Secreted in Endometriotic Cells via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780 via openalex
- Medical management of endometriosis and infertility via openalex
- Medical Management of Endometriosis: Novel Targets and Approaches towards the Development of Future Treatment Regimes via openalex
- Nuclear Factor-κB (NF-κB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large? via openalex
- Peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model via openalex
- Peroxisome proliferator-activated receptor-γ ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis via openalex
- Recurrent endometriosis: Incidence, management, and prognosis via openalex
- Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor, Vitamin D 1α-Hydroxylase, Vitamin D 24-Hydroxylase, and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers via openalex
- Retinoic acid suppresses interleukin-6 production in human endometrial cells via openalex
- Role of Cytokines in Progression of Endometriosis via openalex
- Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells via openalex
- Thiazolidinedione Inhibition of Peritoneal Inflammation via openalex
- Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells via openalex
- W2042618169 via openalex
- W2078741915 via openalex
- W2080393461 via openalex
- W2083436346 via openalex
- W2087908472 via openalex
- W2101779426 via openalex
- W2109525253 via openalex
- W2109801386 via openalex
- W2110953198 via openalex
- W2115782311 via openalex
- W2117740888 via openalex
- W2120176836 via openalex
- W2127125241 via openalex
- W2140916223 via openalex
- W2143715300 via openalex
- W2156646628 via openalex
- W2159969745 via openalex
- W2160829078 via openalex
- W2951765624 via openalex
- W4211081176 via openalex
- W6603163939 via openalex
- W6630373045 via openalex
- W6636669650 via openalex
- W77403056 via openalex
- W6638931909 via openalex
- W201040832 via openalex
- W1500605055 via openalex
- W1505221121 via openalex
- W1512318310 via openalex
- W1580962701 via openalex
- W1631079062 via openalex
- W1633340712 via openalex
- W1639924204 via openalex
- W1647126819 via openalex
- W1852153956 via openalex
- W1970690912 via openalex
- W1971626162 via openalex
- W1977666051 via openalex
- W1980489497 via openalex
- W1992252639 via openalex
- W1997608954 via openalex
- W2006196243 via openalex
- W2010404866 via openalex
- W2012242139 via openalex
- W2016298359 via openalex
- W2036139206 via openalex
- W2039144212 via openalex
Cited by (24)
- The role of peroxisome proliferator-activated receptors in endometriosis 2024
- The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities 2023
- Endometriosis Research: From Bench to Bedside 2022
- Comparative proteomics identify HSP90A, STIP1 and TAGLN-2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis 2022
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
- Recent insights on the genetics and epigenetics of endometriosis 2016
- An Update on Pathophysiology and Medical Management of Endometriosis 2016
- PPARy Expression in Eutopic and Ectopic Endometrium of Reproductive Age Women with Endometriosis 2016
- Potential New Drugs for Endometriosis: Experimental Evidence 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Aberrant histone modification in endometriosis 2014
- Novel agents for the medical treatment of endometriosis 2014
- The Epigenetics of Endometriosis 2012
- Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis 2011
- The emerging role of epigenetics and miRNAs in endometriosis 2011
- Pathogenesis: Epigenetics 2011
- Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target 2011
- DNA microarray analysis in endometriosis for development of more effective targeted therapies 2011
- PPAR–gamma: a dagger in endometriosis 2010
- Molecular profiling of human endometrium and endometriosis 2010
- Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice 2010
- Emerging drugs for endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:30.652814+00:00
License: CC0
· commercial use OK